A service of StreetInsider.com
Ticker Symbol
Welcome

Most Popular

AAPL 496.19
C 32.98
GOOG 607.20
BAC 8.09
RIMM 15.71

Recently Added

CPIC 1.12
SHMX 0.00
NBTH 12.50
COHO 0.00
PZZI 4.77

Gaining Speed

COHO 0.00
SHMX 0.00
CPIC 1.12
NBTH 12.50
IDVC 0.35
16.91 -0.14 (-0.84%) AMLN

Click Here to Receive Instant E-mail and RSS Alerts


Trade AMLN now with

Stock Details

Last Trade:16.91 Change:-0.14 (-0.84%) Prev Close:17.05 Open: 16.61 Days Range:16.60 – 17.00 52 Week Range: 8.03 - 18.30 Volume:1279369 P/E: N/A
EPS:-0.70





Recent Blog Posts

Blog Posts on 02/08/12 at 6:48pm
GlaxoSmithKline: A Good Mix Of Income And Opportunity
Blog Posts on 02/07/12 at 10:06am
Trading Biotech In Pairs: A Better Way To Hedge
Blog Posts on 02/03/12 at 4:09am
Amylin Pharmaceuticals: There Are Better Investment Opportunities In Biotech
Blog Posts on 02/01/12 at 2:41pm
Lilly Has Earned Its Lousy Rep
Blog Posts on 01/27/12 at 3:21pm
Amylin Gets Its Yes; Now For The Hard Work
Blog Posts on 01/25/12 at 10:16am
FDA Pending Catalysts For 5 Biotechs
Blog Posts on 01/23/12 at 8:25am
2 Pharmaceutical Stocks Ready To Move
Blog Posts on 01/20/12 at 12:00pm
Big Pharma, Take Note: Prolor Biotech's CTP Technology Yields Bio-Better Proteins
Blog Posts on 01/12/12 at 6:41am
Portfolio Optimization: Carl Icahn Vs. T. Boone Pickens Vs. Warren Buffett
Blog Posts on 01/09/12 at 4:30pm
The New Amylin - More Risk, More Potential
Blog Posts on 01/03/12 at 4:19pm
7 Healthcare Stocks With January Catalysts
Blog Posts on 12/13/11 at 3:24pm
Biotechs To Benefit From Strategy Shift By Big Pharma
Blog Posts on 12/12/11 at 3:02pm
Lower R&D Budgets For Big Pharma Creating A Brighter Future For The Right Biotechs
Blog Posts on 12/12/11 at 3:56am
5 More High Risk/Reward Biotechs For 2012
Blog Posts on 12/06/11 at 5:23am
A Trading Strategy For 7 Biotech/Healthcare Stocks With Upcoming PDUFA Dates
Blog Posts on 11/23/11 at 8:18am
Billionaire Carl Icahn's Top Stock Picks And Portfolio Activity
Blog Posts on 11/21/11 at 3:59pm
Amylin's Agreement with Lilly Will Not Lead It To Profitablity
Blog Posts on 11/14/11 at 4:11am
5 Companies Awaiting FDA Approval Decisions In Q1 2012
Blog Posts on 11/13/11 at 5:10am
Amylin CEO Sees Break With Lilly On Diabetes Drug As A Plus For Shareholders
Blog Posts on 11/10/11 at 11:03am
Curis Earns $8 Million Milestone As NDA Accepted By FDA
Blog Posts on 11/09/11 at 11:05am
Novo Nordisk Reports Stellar 3rd Quarter Earnings
Blog Posts on 11/08/11 at 12:59pm
Tuesday Options Brief: AMLN, XLNX, DF & NTGR
Blog Posts on 10/25/11 at 12:32pm
Mid-Cap, Large-Cap Biotech Picks By The World's Largest Fund Managers
Blog Posts on 10/19/11 at 9:40pm
Amylin Pharmaceuticals' CEO Discusses Q3 2011 Results - Earnings Call Transcript
Blog Posts on 10/19/11 at 4:58pm
20 Smart Money Picks With Impressive Growth In Profitability
Blog Posts on 10/14/11 at 10:29am
Top Mid- And Large-Cap Biotech Picks By Legendary Fund Managers
Blog Posts on 10/04/11 at 6:26pm
10 Smart Money Picks With Strong Operating Cash Flow Growth
Blog Posts on 10/03/11 at 4:39am
8 Speculative Biotech Buys Based On Last Quarter's Biggest Movers
Blog Posts on 09/27/11 at 11:05am
Tracking Cramer: How 4 Mad Money Picks Performed
Blog Posts on 09/18/11 at 9:21am
11 Stocks Carl Icahn And Jim Simons Are Bullish On